Jason S. Gilbert^1*, Megan Connor, MD^1*, Grace Bosma, MS^2*, Christine M. McMahon, MD³, Maria L Amaya, MD, PhD⁴, Jonathan Gutman, MD³, Marc Schwartz, MD⁵, Andrew Kent, MD, PhD³, Diana Abbott, PhD² and Daniel A Pollyea, MD⁵

¹Department of Medicine, University of Colorado School of Medicine, Aurora, CO
²Center for Innovative Design and Analysis (CIDA), Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO
³Division of Hematology, University of Colorado, Aurora, CO
⁴University of Colorado, Aurora, CO
⁵Division of Hematology, University of Colorado, Denver, CO

Luis E. Aguirre, MD¹, Jan Philipp Bewersdorf, MD², Yiwen Liu^3*, Rory M. Shallis, MD⁴, Leora Boussi, MD⁵, Andrius Zucenka, MD⁶, Sylvain Garciaz, MD^7*, Rebecca P. Bystrom, MD¹, Daniel J. DeAngelo, MD, PhD¹, Richard M. Stone, MD¹, Marlise R. Luskin, MD¹, Jacqueline S. Garcia, MD¹, Eric S. Winer, MD¹, Kelly Ling, PA-C^1*, Evan C. Chen, MD¹, Martha Wadleigh, MD¹, Eytan M. Stein, MD⁵, Aaron D. Goldberg, MD, PhD⁵, Amer M. Zeidan, MBBS, MHS⁸, Shai Shimony, MD¹ and Maximilian Stahl, MD⁹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
³Dana-Farber Cancer Institute, Boston, MA
⁴Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
⁷Institut Paoli-Calmettes, MARSEILLE, France
⁸Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
⁹Dana Farber Cancer Institute, Boston, MA

Agnieszka Pluta^1,2*, Olga Racinska^1*, Magdalena Dutka^3*, Karolina Beldzinska-Gondek^3*, Jan Maciej Zaucha^3*, Natalia Bujko-Wasiak^4,5*, Katarzyna Brzezniakiewicz-Janus^4,5*, Andrzej Szczepaniak, MD^6*, Zuzanna Rzetelska^6*, Lidia Gil, MD, PhD⁶, Ryszard Swoboda^7*, Sebastian Giebel, MD, PhD^7*, Marta Sobas, MD^8*, Krzysztof Madry^9*, Michal Górka^9*, Grzegorz Basak^9*, Anna Labedz^10*, Malgorzata Razny^10*, Agnieszka Kopacz^11*, Kamila Kruczkowska-Tarantowicz^12*, Piotr Rzepecki^12*, Magdalena Czemerska^1,2*, Piotr Strzalka^1,2*, Kinga Krawiec^1,2*, Jerzy Holowiecki^7* and Agnieszka Wierzbowska^1,2

¹Department of Hematology, Medical University of Lodz, Lodz, Poland
²Department of Hematology and Transplantology, Multidisciplinary Provincial Centre of Traumatology and Oncology Nicolas Copernicus in Lodz, Lodz, Poland
³Department of Hematology and Transplantology, Medical University of Gdansk and University Clinical Center in Gdansk, Gdansk, Poland
⁴Department of Hematology, Multidisciplinary Provincial Hospital, Gorzów Wielkopolski, Poland
⁵Collegium Medicum, University of Zielona Góra, Gorzów Wielkopolski, Poland
⁶Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
⁷Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
⁸Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University of Wroclaw, Wroclaw, Poland
⁹Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
¹⁰Hematology Department, Rydygier Memorial Hospital, Krakow, Poland
¹¹Department of Hematology, Medical University of Rzeszow, Rzeszow, Poland
¹²Department of Clinical Hematology, Military Medical Academy, Warsaw, Poland

Baher Krayem, MD^1*, Avraham Frisch, MD^1*, Tsila Zuckerman, MD², Israel Henig, MD^1*, Dana Yehudai-Ofir, MD^1*, Boaz Nachmias, MD, PhD^3*, Hazim Khatib, MD^1*, Arnon Haran^3* and Shlomzion Aumann^3*

¹Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
²Department of Hematology and BMT, Rambam Health Care Campus, Haifa, Israel
³Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

Onyee Chan, MD¹, Kendra L. Sweet, MD¹, Chetasi Talati, MD², Fatima Tuz Zahra, MBBS³, Lisa Ann Nardelli, BS^4*, Jatinder K. Lamba, PhD⁵, Jongphil Kim, PhD^6*, Jinming Song, MD, PhD^7*, Zhuoer Xie, MD, MS⁸, Seongseok Yun, MD, PhD¹, Andrew T. Kuykendall, MD¹, Eric Padron, MD¹, Alison R. Walker, MD, MBA, MPH¹, Rami S. Komrokji, MD¹, Jeffrey E Lancet, MD¹ and David Sallman, MD⁹

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²AbbVie, Inc., Collierville, TN
³Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, ALBANY, NY
⁴Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL
⁵Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL
⁶Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁸Department of Malignant Hematology, Moffitt Cancer Center, Lutz, FL
⁹Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Jennifer Croden, MD¹, Danielle Hammond, MD¹, Kelly S. Chien, MD², Abhishek Maiti, MBBS³, George Donovan Tippett, BS, BSN, RN^1*, Guillermo Montalban-Bravo, MD¹, Michael Morales, BSN, RN^4*, Nicholas J. Short, MD¹, Hussein A. Abbas, MD, PhD¹, Ghayas C. Issa, MD¹, Tapan M. Kadia, MD¹, Gautam Borthakur, MD⁵, Farhad Ravandi, MBBS⁶ and Courtney D. DiNardo, MD, MSc⁷

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, MD Anderson, Houston, TX
³Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
⁴Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX

Vanthana Bharathi, MD^1*, Alex Bataller, MD, PhD^2*, Alexandre Bazinet, MD^1*, Gautam Borthakur, MD³, Elias Jabbour, MD⁴, Naval Daver, MD⁵, Nicholas J. Short, MD¹, Koichi Takahashi, MD, PhD¹, Ghayas C. Issa, MD¹, Courtney D. DiNardo, MD, MSc⁶, Naveen Pemmaraju, MD⁷, Nitin Jain, MD¹, Guillermo Montalban-Bravo, MD¹, William G. Wierda², Farhad Ravandi, MBBS⁸, Hagop M. Kantarjian, MD¹ and Tapan M. Kadia, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
⁵MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
⁸Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Eshrak Al-Shaibani^1*, Marta Beata Davidson, MD, PhD¹, Aniket Bankar, MD, MBBS, MSc, DM¹, Steven M. Chan, MD, PhD¹, Hassan Sibai, MD¹, Dawn C. Maze, MD, FRCPC, MSc¹, Aaron D Schimmer, MD², Mark D. Minden, MD, PhD^1*, Karen Yee, MD, FRCPC^1*, Vikas Gupta, MD, FRCP, FRCPath¹, Andre C. Schuh, MD, FRCPC¹ and Guillaume Richard-Carpentier, MD, FRCPC¹

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
²Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Jiajia Pan^1,2,3,4*, Nianci Chen^1,2,3,4*, Liping Mao, M.D.^1,2,3,4*, Yinjun Lou, MD, PhD^1,2,3,4*, Yi Zhang^1,2,3,4*, Shanshan Suo, MD^1,2,3,4*, Yile Zhou, MD^1,2,3,4*, Chenying Li, PhD^1,2,3,4*, Xia Li^1,2,3,4*, Xueying Yang, M.D.^1,2,3,4*, Qing Ling^1,2,3,4*, Wenle Ye^1,2,3,4*, Xiangjie Lin^1,2,3,4*, Huafeng Wang^1,2,3,4* and Jie Jin^1,2,3,4

¹Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China
²Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China
³Zhejiang University Cancer Center, Hangzhou, China
⁴Department of Hematology,the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Pierre-Yves Dumas, MD, PhD^1*, Sarah Bertoli, MD^2*, Clémence Santana^3*, Mael Heiblig^4*, Thibaut Leguay, MD^5*, Suzanne Tavitian, MD^6*, Eric Delabesse, MD, PhD^7*, Émilie Klein, MD^8*, Emmanuelle Tavernier, MD^9*, Martin Carre, MD^10*, Gaspar Aspas Requena^11*, Anne Banos, MD^12*, Norbert Vey, MD¹³, Arnaud Pigneux, MD, PhD^14*, Christian Récher, MD, PhD¹⁵ and Sylvain Garciaz, MD^16*

¹CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, F-33000 Bordeaux, France;BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, F-33000 Bordeaux, France, Bordeaux, France
²Service d'Hématologie, Centre Hospitalo-universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse, UPS, INSERM, CNRS, Toulouse, France, Toulouse, France
³Département d'Hématologie, CH de Valence, Valence, France
⁴Hematology Department, Hospices Civils de Lyon, Pierre Bénite, Lyon, France, LYON, FRA
⁵Hematology, CHU Bordeaux, Hôpital du Haut-Lévêque, Pessac, France
⁶Department of Hematology, Toulouse University Cancer Institute Oncopole, Toulouse University Hospital, Toulouse, France
⁷University Hospital of Toulouse, University of Toulouse 3, Center of Research On, Toulouse, NA, FRA
⁸Service Hématologie Biologique, CHU Bordeaux, Bordeaux, France
⁹Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
¹⁰Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
¹¹CHU Clermont-Ferrand, Clermont-Ferrand, France
¹²Centre Hospitalier De Bayonne, Bayonne, FRA
¹³Department of Hematology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille, France
¹⁴Department of Clinical Hematology, Haut-Lévèque Hospital, CHU Bordeaux, Pessac, France
¹⁵Hematology Department, CHU deToulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
¹⁶Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France; Centre National de la Recherche Scientifique, UMR7258, Marseille, France; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France, Marseille, France

Xiwen Tong^1*, Bin Xu^1*, Shiyuan Zhang^1*, Xiaojian Zhu^1*, Mengyuan Li^2*, Su Shuai^1*, Yi Zhu^1*, Zhenqian Huang^3*, Yaya Wang^3*, Yi Xiao^1*, Liang Huang⁴, Dengju Li^1*, Wei Huang^1*, Jia Wei¹, Mei Huang^1*, Zhiping Huang^5*, Yuanyan Tang^5*, Hongbo Ren^6* and Donghua Zhang^1*

¹Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Department of hematology, Taihe Hospital, Hubei University of Medicine, Shiyan, China
³The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
⁴Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
⁵Jingzhou Central Hospital, Jingzhou, China
⁶Jingzhou First People’s Hospital, Jingzhou, China

Alexandre Bazinet, MD^1*, Naval Daver, MD², Farhad Ravandi, MBBS³, Nicholas J. Short, MD¹, Musa Yilmaz, MD¹, Maro Ohanian, DO^1*, Jo Ishizawa, MD, PhD⁴, Abhishek Maiti, MBBS⁵, Courtney D. DiNardo, MD, MSc⁶, Lucia Masarova, MD¹, William G. Wierda⁷, Kelly S. Chien, MD⁸, Elias Jabbour, MD⁷, Danielle Hammond, MD¹, Fadi G. Haddad, MD¹, Koji Sasaki, MD¹, Alex Bataller, MD, PhD^1*, Debra Bull-Linderman, RN^9*, Gautam Borthakur, MD⁴, Guillermo Garcia-Manero, MD¹, Hagop M. Kantarjian, MD¹⁰ and Tapan M. Kadia, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
⁶Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁷The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, MD Anderson, Houston, TX
⁹Department of Leukemia, MD Anderson Cancer Center, Houston, TX
¹⁰University of Texas MD Anderson Cancer Center, Houston, TX

Jaime E. Connolly Rohrbach, PhD^1*, Edward Waldron^1*, Li Liu^2*, Shawn Rivera^3*, Sridevi Kayyur Subramanya^3*, Violet Abraham^3*, Alexander E. Perl, MD⁴ and Mark J. Levis⁵

¹Daiichi Sankyo, Inc., Basking Ridge, NJ
²Daiichi Sankyo, Inc, Basking Ridge, NJ
³Navigate BioPharma Services, Inc., Carlsbad, CA
⁴Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

ZePing Zhou, MD, PhD¹, Yaxian Tan^2*, Xingli Zhao^3*, Xiaohui Suo^4*, Guanchen Bai^5*, Yanliang Bai, MD^6*, Yunya Luo^7*, Xinxiao Lu^8*, Linyu Yuan^8*, Congcong Zhang^9*, Yinling Li^10*, Sifeng Gao^5*, Jilei Zhang^5*, Hongling Peng, MD^11*, Pengxiang Guo^12*, Yingchang Mi, MD¹³ and Kaiqi Liu^13*

¹The Second Affiliated Hospital of Kunming Medical University, Kunming, Alabama, China
²Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China, Kunming, China
³Department of Hematology, Oncology Center, Tianjin People's Hospital, No. 190 jieyuan Road, Hongqiao District,, Tianjin, China
⁴Department of Hematology, Handan Central Hospital, Handan, Hebei, China., Handan, China
⁵Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China, 271000., Taian, China
⁶Department of Hematology, Zhengzhou University People's Hospital and Henan Provincial People's Hospital, Zhengzhou, China
⁷Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, People's Republic of China., Changsha, China
⁸Department of Hematology, Oncology Center, Tianjin People's Hospital, No. 190 jieyuan Road, Hongqiao District, Tianjin 300121, P R China., Tianjin, China
⁹Department of Hematology, Handan Central Hospital, Handan, Hebei, China, 056000, Handan, China
¹⁰Department of Hematology, Handan Central Hospital, Handan, Hebei, China, 056000,, Handan, China
¹¹Department of hematology, The second xiangya hospital of Central South University, Changsha, China
¹²Department of Hematology, Guizhou Provincial People’s Hospital, Guiyang, Guizhou, China, Guiyang, China
¹³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China, Tianjin, China

Yafang Ma^1*, Xiang Zhang^2*, Jian Hou^3*, Lijing Shen^4*, Fei Li⁵, Fancong Kong^6*, Ying Lu^7*, Guowei Li^8*, Jie Jin, M.D.⁹ and Wenjuan Yu^10*

¹The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, CHN
²Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
³Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁴Department of Hematology, Renji hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁵Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
⁶Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
⁷Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
⁸Department of Hematology, Huizhou Municipal Central Hospital, Huizhou, China
⁹Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
¹⁰Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Leora Boussi, MD¹, Jan Philipp Bewersdorf, MD², Yiwen Liu, MS^3*, Rory M. Shallis, MD⁴, Luis E. Aguirre^5*, Andrius Zucenka, MD⁶, Sylvain Garciaz, MD^7*, Rebecca P. Bystrom, MD⁵, Daniel J. DeAngelo, MD, PhD⁸, Richard M Stone, MD⁹, Marlise R. Luskin, MD⁹, Jacqueline S. Garcia, MD⁹, Eric S. Winer, MD⁹, Evan Chen, MD^10*, Martha Wadleigh, MD⁹, Kelly Ling, PA-C^9*, Amer M. Zeidan, MBBS, MHS², Aaron D. Goldberg, MD, PhD¹, Eytan M. Stein, MD¹¹, Shai Shimony, MD⁹ and Maximilian Stahl, MD¹²

¹Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
³Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
⁵Dana-Farber Cancer Institute, Boston, MA
⁶Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
⁷Institut Paoli-Calmettes, MARSEILLE, France
⁸Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA
⁹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
¹¹Department of Medicine; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
¹²Dana Farber Cancer Institute, Boston, MA

Michelle Hyunju Lee, MD¹, Wyatt McCall, MD^2*, Joanna Cwykiel, PhD^3*, Chenyu Lin, MD⁴, Ellen Madarang, PharmD^5*, Justin M. Watts, MD⁵, Harry P. Erba, MD, PhD⁴, Yasmin Abaza, MD³, Alexander E. Perl, MD⁶, Andrew H Matthews, MD^7*, Andrew M. Brunner, MD⁸ and Amir T. Fathi, MD⁹

¹Department of Medical Oncology, Massachusetts General Hospital, Boston, MA
²University of Pennsylvania, Philadelphia, PA
³Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
⁴Duke University Cancer Institute, Durham, NC
⁵Leukemia Service, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL
⁶Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁷Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁸Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
⁹Center for Leukemia, Massachusetts General Hospital Cancer Center, Boston, MA

Guopan Yu, MD, PhD^1*, Zurong Yao^1*, Zhao Yin^1*, Yu Zhang, MD^1*, Weihua Zhao, MD^2*, Guangyang Weng, MD^3*, Ziwen Guo^4*, Zhiqiang Sun, MD, PhD^5*, Pengcheng Shi^1*, Xuejie Jiang, M.D.^6*, Dan Xu^1*, Li Xuan^1* and Qifa Liu, MD¹

¹Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
²Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
³Department of Hematology, Shenzhen Second People's Hospital, Shenzhen, China
⁴Department of Hematology, Zhongshan City People’s Hospital, Zhongshan, China
⁵Department of Hematology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
⁶Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

Xuekai Li^*, Mengyun Li^*, Wei Cui^*, Xiaoqian Chen^*, Yan Yu^*, Juan Chen^*, Xin Zhang^*, Qingya Cui^*, Depei Wu, MD, PhD and Xiaowen Tang^*

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Manuel Jorge Fernández Villalobos^1*, Javier Ortiz, MD^2*, Angela Figuera Alvarez, MD, PhD^3*, Carlos De Miguel, MD^4*, Almudena De Laiglesia, MD^5*, Virginia Pradillo Fernandez, MD^6*, Marina Diaz Beya, MD^7*, Jordi Esteve, MD, PhD^7,8,9,10,11, Marta Polo, MD^12*, Mayte Olave, MD^13*, Maria del Mar Moles, MD^13*, Amparo Pimentel, MD^14*, Ramon Garcia-Sanz, MD, PhD^15,16 and Gabriela Rodriguez Macias, MD¹⁷

¹Department of Hematology, Hospital General Universitario Gregorio Marañon, Badajoz, Spain
²Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain
³Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain
⁴Hospital Universitario Puerta de Hierro, Madrid, Spain
⁵Department of Hematology, Hospital Universitario Puerta de Hierro, Madrid, Spain
⁶Department of Hematology., Hospital Universitario Quirónsalud, Madrid, Spain
⁷Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
⁸Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
⁹Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
¹⁰Universitat de Barcelona, Barcelona, Spain
¹¹Hematology Department, Hospital Clínic Barcelona, ICAMS, Barcelona, Spain
¹²Department of Hematology, Hospital Universitario Clinico San Carlos, Madrid, Spain
¹³Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
¹⁴Department of Hematology, Hospital Universitario de Jaén, Jaén, Spain
¹⁵Health Research Institute Gregorio Marañón, Madrid, Spain
¹⁶General University Hospital Gregorio Marañón, Madrid, Spain
¹⁷Department of Hematology, Hospital Universitario Gregorio Maranon, Madrid, Spain

Uma Borate, MD¹, Kaitlyn M. Dvorak-Kornaus, PhD^2*, Qiuhong Zhao, MS^2*, Roland B. Walter, MD, PhD, MS³, Rachel J. Cook, MD, MS⁴, Jennifer N. Saultz, DO⁵, Ronan T. Swords, MD, PhD, FRCP, FRCPath⁵, Nicole R. Grieselhuber, MD, PhD⁶, Alice Mims, MD⁷, Karilyn T. Larkin, MD⁸, Kieran D Sahasrabudhe, MD⁹, James S. Blachly, MD¹, Gregory K Behbehani, MD, PhD⁸, Ann-Kathrin Eisfeld, MD¹, Meixiao Long, MD, PhD⁸, Andrew Srisuwananukorn, MD¹ and Kristin L Koenig, MD⁸

¹The Ohio State University, Columbus, OH
²Division of Hematology, The Ohio State University, Columbus, OH
³Fred Hutchinson Cancer Center, Seattle, WA
⁴Oregon Health & Science University, Portland, OR
⁵Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁶Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
⁷The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁸Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
⁹The University of Wisconsin Carbone Cancer Center, Madison, WI

Ziyu Feng, MD^1*, Xiaohui Hu^1*, Weiyang Li^1*, Ting Xu^1*, Yang Xu, MD^2*, Shengli Xue^2*, Huiying Qiu^1*, Xiaowen Tang^1*, Yue Han, MD, PhD^3*, Suning Chen, MD, PhD^1*, Aining Sun, MD, PhD^2*, Depei Wu, MD, PhD⁴ and Ying Wang, MD, PhD^1*

¹The First Affiliated Hospital of Soochow University, Suzhou, China
²National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
³Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
⁴Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Suravi Raychaudhuri, MD^1,2, Ted Gooley, PhD^2*, Allegra Rasmussen^1*, Kim Quach^1*, Zach Gill^1*, Anna B. Halpern, MD^1,2, Jacob S. Appelbaum, MD, PhD^2,3, Cristina Maria Ghiuzeli, MD^1,2, Paul C. Hendrie, MD, PhD^1,2*, Ryan D. Cassaday, MD^1,2, Roland B. Walter, MD, PhD, MS^4,5, Elihu Estey, MD^1,2* and Mary-Elizabeth M. Percival, MD^3,6

¹Fred Hutchinson Cancer Center, Seattle, WA
²University of Washington, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁴Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA
⁶Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA

Nicholas J. Short, MD¹, Farhad Ravandi, MBBS², Naval Daver, MD³, Courtney D. DiNardo, MD, MSc⁴, Gautam Borthakur, MD⁵, Tapan M. Kadia, MD¹, Musa Yilmaz, MD¹, Ghayas C. Issa, MD¹, Regina Abramova^6*, Araceli Isabella Garza^1*, Hagop M. Kantarjian, MD¹ and Hussein A. Abbas, MD, PhD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
³MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁵Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶The University of Texas MD Anderson Cancer Center, Houston, TX